These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29217578)

  • 1. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
    Zhou Y; Castonguay P; Sidhom EH; Clark AR; Dvela-Levitt M; Kim S; Sieber J; Wieder N; Jung JY; Andreeva S; Reichardt J; Dubois F; Hoffmann SC; Basgen JM; Montesinos MS; Weins A; Johnson AC; Lander ES; Garrett MR; Hopkins CR; Greka A
    Science; 2017 Dec; 358(6368):1332-1336. PubMed ID: 29217578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal physiology: TRPC5 inhibition to treat progressive kidney disease.
    van der Wijst J; Bindels RJM
    Nat Rev Nephrol; 2018 Mar; 14(3):145-146. PubMed ID: 29355170
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the TRPC5 ion channel protects the kidney filter.
    Schaldecker T; Kim S; Tarabanis C; Tian D; Hakroush S; Castonguay P; Ahn W; Wallentin H; Heid H; Hopkins CR; Lindsley CW; Riccio A; Buvall L; Weins A; Greka A
    J Clin Invest; 2013 Dec; 123(12):5298-309. PubMed ID: 24231357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
    Polat OK; Isaeva E; Sudhini YR; Knott B; Zhu K; Noben M; Suresh Kumar V; Endlich N; Mangos S; Reddy TV; Samelko B; Wei C; Altintas MM; Dryer SE; Sever S; Staruschenko A; Reiser J
    Kidney Int; 2023 Jun; 103(6):1056-1062. PubMed ID: 36750145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.
    Chen L; Zhang Z; Tian H; Jiang S; Ji Y; Liu M; Shen J; Cao Z; Wang K
    Bioorg Med Chem; 2022 Aug; 68():116853. PubMed ID: 35653869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.
    Sharma SH; Pablo JL; Montesinos MS; Greka A; Hopkins CR
    Bioorg Med Chem Lett; 2019 Jan; 29(2):155-159. PubMed ID: 30538066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models.
    Zhou Y; Kim C; Pablo JLB; Zhang F; Jung JY; Xiao L; Bazua-Valenti S; Emani M; Hopkins CR; Weins A; Greka A
    Front Med (Lausanne); 2021; 8():721865. PubMed ID: 34621762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
    Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
    Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.
    Pablo JL; Greka A
    Trends Pharmacol Sci; 2019 Dec; 40(12):911-918. PubMed ID: 31704171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPC5 Does Not Cause or Aggravate Glomerular Disease.
    Wang X; Dande RR; Yu H; Samelko B; Miller RE; Altintas MM; Reiser J
    J Am Soc Nephrol; 2018 Feb; 29(2):409-415. PubMed ID: 29061651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species.
    Stamellou E; Agrawal S; Siegerist F; Buse M; Kuppe C; Lange T; Buhl EM; Alam J; Strieder T; Boor P; Ostendorf T; Gröne HJ; Floege J; Smoyer WE; Endlich N; Moeller MJ
    Nephrol Dial Transplant; 2024 Jun; 39(7):1181-1193. PubMed ID: 38037533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903.
    Baradaran-Heravi A; Bauer CC; Pickles IB; Hosseini-Farahabadi S; Balgi AD; Choi K; Linley DM; Beech DJ; Roberge M; Bon RS
    J Biol Chem; 2022 Feb; 298(2):101546. PubMed ID: 34999117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
    Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
    Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.